Reuters logo
BRIEF-CTI Biopharma reports third quarter 2017 financial results
November 6, 2017 / 11:02 PM / a month ago

BRIEF-CTI Biopharma reports third quarter 2017 financial results

Nov 6 (Reuters) - CTI Biopharma Corp:

* CTI Biopharma reports third quarter 2017 financial results

* Q3 loss per share $0.28

* CTI Biopharma Corp - ‍total revenues for q3 were $1.7 million compared to $4.4 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below